P2847The role of the hippo-pathway in the pathogenesis of doxorubicin-induced cardiomyopathy

Michela Relucenti; Vincenzo Petrozza; Giacomo Frati; Sebastiano Sciarretta; Leonardo Schirone; Daniele Vecchio; Maurizio Forte; Sonia Schiavon; Silvia Palmerio; Selenia Miglietta; Elisa Mangione; Michele Madonna

doi:10.1093/eurheartj/ehy565.p2847

Article2023

MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation

Leonardo Schirone, Daniele Vecchio, Valentina Valenti, Maurizio Forte, Michela Relucenti, Annalisa Angelini, Tania Zaglia, Sonia Schiavon, Luca D’Ambrosio, Gianmarco Sarto, Rosita Stanzione, Elisa Mangione, Selenia Miglietta, Anna Di Bona, Marny Fedrigo, Alessandra Ghigo, Francesco Versaci, Vincenzo Petrozza, Simona Marchitti, Speranza Rubattu, Massimo Volpe, Junichi Sadoshima, Luigi Frati, Giacomo Frati, Sebastiano Sciarretta

Article2015

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis

Toshiro Moroishi, Hyun Woo Park, Bao‐Dong Qin, Qian Chen, Zhipeng Meng, Steven W. Plouffe, Koji Taniguchi, Fa‐Xing Yu, Michael Karin, Duojia Pan, Kun‐Liang Guan

Article2019

Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease

Anastasios Kyriazoglou, Ioannis Ntanasis‐Stathopoulos, Evangelos Terpos, Despina Fotiou, Efstathios Kastritis, Meletios A Dimopoulos, Maria Gavriatopoulou

Article2024

Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma

Anastasios Kyriazoglou, Dionysios J. Papachristou, Myrto Moutafi, ALEXANDRA PAPAKOSTA, Alkistis Papatheodoridi, Maria Kaparelou, Anna-Maria Korakiti, Michalis Liontos, Meletios A Dimopoulos, Flora Zagouri

Article2011

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

Geert C. van Almen, Melissa Swinnen, Paolo Carai, Wouter Verhesen, Jack P.M. Cleutjens, Jan D’hooge, Fons K. Verheyen, Yigal M. Pinto, Blanche Schroen, Peter Carmeliet, Stéphane Heymans

P2847The role of the hippo-pathway in the pathogenesis of doxorubicin-induced cardiomyopathy

Discussion(0)

Related publications

MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis

Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease

Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy